1887

n CME : Your SA Journal of CPD - Secondary preventive therapy in smoking-related COPD : more about... pulmonary

USD

 

Abstract

Lung function decline in patients who continue to smoke is inexorable. The rate of decline exceeds that which occurs as a normal consequence of ageing, leading to impairment of normal daily activities and quality of life. Despite our current knowledge of COPD, to date there is no known pharmacological agent which abrogates disease progression.

Loading

Article metrics loading...

/content/m_cme/27/4/EJC63640
2009-04-01
2016-12-06
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error